Literature DB >> 15235826

Continuous infusion of vecuronium in children.

H Obara1, H Hoshina, O Tanaka, R Chuma, H Kaetsu, N Maekawa, S Iwai.   

Abstract

The average dose of vecuronium required in children continuous infusion to attain a steady state block of 90% was determined. The electromyographic (EMG) response and mechanical response to supramaximal stimulation of the ulnar never recorded simultaneously, were significantly correlated in four children. The steady-state infusion rate requirement of vecuronium was 1.4 +/- 0.03 micro g/kg/min during 2% enflurane anesthesia and 3.1 +/- 0.03 micro g/kg/min during 1% halothane anesthesia. The spontaneous recovery time to 25% of the control by EMG during halothane and enflurane anesthesia was 12.6 +/- 1.1 and 10.3 +/- 1.5 min, respectively, after termination of the infusion. There was no cumulative effect after prolonged vecuronium infusion.

Entities:  

Year:  1988        PMID: 15235826     DOI: 10.1007/s0054080020008

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  8 in total

1.  The neuromuscular transmission monitor. A clinical assessment and comparison with a force transducer.

Authors:  J P Windsor; P S Sebel; P J Flynn
Journal:  Anaesthesia       Date:  1985-02       Impact factor: 6.955

2.  Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.

Authors:  G Noeldge; H Hinsken; W Buzello
Journal:  Br J Anaesth       Date:  1984-05       Impact factor: 9.166

Review 3.  Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants.

Authors:  J C Hilgenberg
Journal:  Anesth Analg       Date:  1983-05       Impact factor: 5.108

4.  Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.

Authors:  M R Fahey; R B Morris; R D Miller; Y J Sohn; R Cronnelly; P Gencarelli
Journal:  Anesthesiology       Date:  1981-07       Impact factor: 7.892

5.  The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study.

Authors:  S Agoston; P Salt; D Newton; A Bencini; P Boomsma; W Erdmann
Journal:  Br J Anaesth       Date:  1980       Impact factor: 9.166

Review 6.  Clinical pharmacology of vecuronium and atracurium.

Authors:  R D Miller; S M Rupp; D M Fisher; R Cronnelly; M R Fahey; Y J Sohn
Journal:  Anesthesiology       Date:  1984-10       Impact factor: 7.892

7.  Neuromuscular effects of vecuronium (ORG NC45) in infants and children during N2O, halothane anesthesia.

Authors:  D M Fisher; R D Miller
Journal:  Anesthesiology       Date:  1983-06       Impact factor: 7.892

8.  Vecuronium infusion dose requirements during fentanyl and halothane anesthesia in humans.

Authors:  J Swen; P J Gencarelli; H W Koot
Journal:  Anesth Analg       Date:  1985-04       Impact factor: 5.108

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.